Rafael Holdings

$1.96 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Rafael Holdings

Rafael Holdings, Inc. owns interests in pre-clinical and clinical stage pharmaceutical companies and commercial real estate assets. The Company operates through two segments: Pharmaceuticals and Real Estate. The Pharmaceuticals segment is comprised of preferred and common equity interests and the Warrant to purchase equity interests in Rafael Pharmaceuticals, a majority equity interest in LipoMedix, Barer, Levco, Farber and Rafael Medical Devices. The Real Estate segment consists of the Company's real estate holdings, including a building at 520 Broad Street in Newark, New Jersey that houses headquarters for the Company and certain affiliates and its associated public garage and a portion of an office building in Israel.

Stock Analysis

last close $1.96
1-mo return -8.8%
3-mo return -38.7%
avg daily vol. 113.19T
52-week high 66.44
52-week low 1.6
market cap. $35M
forward pe -
annual div. -
roe -115.6%
ltg forecast -
dividend yield -
annual rev. $4M
inst own. 37.1%

Subscribe now for daily local and international financial news